Initial Marketing Strategies

Reflecting on the marketing approach from 2017, it’s challenging to recall the specifics, but health professionals were informed that Ozempic was aimed at managing type 2 diabetes. Its key selling feature was a weekly injection, particularly beneficial for patients who struggled with traditional medications like Metformin.

Sales were initially lackluster, likely due to the steep cost and Novo Nordisk's reluctance to undermine its insulin products such as NovoMix, which often receive government support.

Weight Loss Potential Acknowledged

The weight loss effects of Ozempic have been recognized for some time, even back in 2017. Although a study supporting this was funded by Novo Nordisk, which raises concerns about bias, it did indicate that patients could experience weight reduction and improved blood sugar levels after several weeks of treatment.

This research likely played a role in promoting off-label prescriptions for Ozempic as an anti-obesity drug.

Why Choose Ozempic?

While Ozempic is not the only option available for weight management—other medications like Jardiance and Orlistat exist—its popularity has surged. Personally, I have not used anti-obesity medications, but I am familiar with them through my professional experiences.

In the past, I sold weight loss shakes and programs at a pharmacy, which often did not yield positive results for customers. One customer, frustrated with her shake program's ineffectiveness, snapped at me to "mind my own business." This interaction highlighted the struggles many face with traditional weight loss methods.

In contrast, Orlistat has been around for some time, but its sales have not skyrocketed due to undesirable side effects. The medication inhibits fat absorption, leading to uncomfortable digestive issues, which deters potential users.

Conversely, I witnessed a family member with type 2 diabetes benefit from Ozempic. His significant weight loss raised initial concerns about his health, but I later learned it was due to his new diabetes medication. He reported no side effects, reinforcing my understanding of Ozempic's appeal.

The TikTok Phenomenon

Ozempic's popularity soared when TikTok users began showcasing its benefits. Although I'm not a TikTok user myself, a brief online search reveals numerous transformation stories and a thriving Ozempic hashtag. It's evident that social media can propel products into the spotlight, and TikTok played a significant role in Ozempic's virality.

This phenomenon can be attributed to a psychological concept known as social proof. When people observe many others engaging in a behavior, they are more inclined to follow suit.

It seems that Novo Nordisk did not originally design Ozempic as an anti-obesity treatment, as it primarily stimulates a receptor that is typically underactive in diabetics. The effects of the drug in non-diabetics remain inadequately researched, with substantial studies on its anti-obesity impact only emerging recently (for instance, a relevant meta-analysis was published in 2022).

Despite the unforeseen popularity, Ozempic's side effects are now celebrated by many users.

Concluding Thoughts

In conclusion, while the anti-obesity effects of Ozempic could have been anticipated, particularly for those with type 2 diabetes, predicting its explosive rise on social media was less feasible. The nature of virality is inherently unpredictable; despite my attempts to generate popular content, I have yet to achieve similar success.

Novo Nordisk's CEO discusses Wegovy, Ozempic, profit forecasts, and the US market.

An NBC News exclusive where the CEO of Novo Nordisk addresses high prices and drug shortages related to Ozempic and Wegovy.

Subscribe to DDIntel here.

Submit your work to DDIntel here.

Join our creator ecosystem here.

DDIntel captures the most notable pieces from our main site and our popular DDI Medium publication. Check us out for more insightful work from our community.

Follow us on LinkedIn, Twitter, YouTube, and Facebook.